| Jeanne M Rothamel, RN | |
|
312 9th St Sw, Ste 3000, Waverly, IA 50677-2929 | |
| (319) 352-8891 | |
| (319) 352-8896 |
| Full Name | Jeanne M Rothamel |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Otorhinolaryngology & Head-neck |
| Location | 312 9th St Sw, Waverly, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619962065 | NPI | - | NPPES |
| 059176 | Other | IA | RN LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WX0601X | Registered Nurse - Otorhinolaryngology & Head-neck | 059176 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeanne M Rothamel, RN 312 9th St Sw, Ste 3000, Waverly, IA 50677-2929 Ph: (319) 352-8891 | Jeanne M Rothamel, RN 312 9th St Sw, Ste 3000, Waverly, IA 50677-2929 Ph: (319) 352-8891 |
News Archive
The Muscular Dystrophy Association today celebrated news of the U.S. Food and Drug Administration's decision to grant approval for nusinersen (brand name Spinraza), the first disease-modifying drug to treat the most common genetic cause of death in infants.
IntegenX, Inc. today at the 60th Annual American Society of Human Genetics Meeting announced the launch of their Apollo 324 System, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing.
Results of a new study strongly suggest that DN-101, a new high-dose calcitriol pill designed specifically as a cancer therapy, given in combination with docetaxel (Taxotere) extends the lives of men with advanced prostate cancer.
Critically ill patients in hospital intensive care units (ICUs) are routinely prescribed acid-suppressive medications to reduce their risk of developing stress ulcers and gastrointestinal bleeding, both of which can result from being in a stressful environment and from being intubated. Over the years, this routine practice has often been extended to patients outside the ICU, despite a lack of evidence that this population is at significant risk of these complications.
Vital Therapies, Inc., is pleased to announce that the first subject has been enrolled at National Guard Hospital in Riyadh, Kingdom of Saudi Arabia in the further expansion of its SILVER clinical trial to the Middle East. The trial is evaluating whether VTI's biological cellular therapy product, ELAD, can prevent deterioration of liver function and improve the survival of patients with acute-on-chronic liver failure.
› Verified 1 days ago
Ms. Amber Jane Lacina, BSN, RN, MSN, APMHNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 111 10th St Sw, Waverly, IA 50677 Phone: 319-352-1353 Fax: 319-352-2329 | |
Charity Fecht, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 217 E Bremer Ave Ste E, Waverly, IA 50677 Phone: 319-352-6400 | |
Angela Lynn Schmitt, RN, NUTRITIONIST Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 606 30th St Se, Waverly, IA 50677 Phone: 319-230-3531 | |
Jane Francine Freeseman, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 10th St Sw, Waverly, IA 50677 Phone: 319-352-2064 Fax: 319-352-2329 | |
Katherine A Kubik, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 10th St Sw, Waverly, IA 50677 Phone: 319-352-2064 Fax: 319-352-2329 |